$3.08 Billion is the total value of Avidity Partners Management LP's 96 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 114.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVTR | Buy | AVANTOR INC | $184,853,000 | +80.2% | 6,566,700 | +43.9% | 6.00% | +26.1% |
| ARVN | Buy | ARVINAS INC | $151,800,000 | +376.9% | 1,787,358 | +32.6% | 4.93% | +233.6% |
| ABBV | Sell | ABBVIE INC | $145,295,000 | +8.9% | 1,356,000 | -11.0% | 4.72% | -23.8% |
| LLY | New | LILLY ELI & CO | $136,845,000 | – | 810,500 | +100.0% | 4.44% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $114,977,000 | – | 2,300,000 | +100.0% | 3.73% | – |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS I | $96,654,000 | – | 3,445,772 | +100.0% | 3.14% | – |
| DGX | Buy | QUEST DIAGNOSTIC INC | $94,395,000 | +105.1% | 792,100 | +97.0% | 3.06% | +43.6% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $87,067,000 | – | 992,900 | +100.0% | 2.83% | – |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $85,534,000 | +18.4% | 1,169,300 | +25.7% | 2.78% | -17.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $83,463,000 | +82.8% | 380,000 | +38.2% | 2.71% | +28.0% |
| IMAB | Buy | I MABsponsored ads | $75,016,000 | +19.0% | 1,591,000 | +18.7% | 2.44% | -16.7% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $73,570,000 | +168.8% | 3,308,000 | +78.4% | 2.39% | +88.2% |
| Buy | BIOGEN INCcall | $60,749,000 | +0.0% | 248,100 | +15.9% | 1.97% | -30.0% | |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $58,952,000 | +99.5% | 1,135,000 | +25.5% | 1.91% | +39.6% |
| CHNG | Buy | CHANGE HEALTHCARE INC | $57,481,000 | +56.7% | 3,082,100 | +21.9% | 1.87% | +9.7% |
| STTK | New | SHATTUCK LABS INC | $49,203,000 | – | 938,813 | +100.0% | 1.60% | – |
| NTRA | Sell | NATERA INC | $47,750,000 | +31.3% | 479,800 | -4.7% | 1.55% | -8.1% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $47,711,000 | – | 621,000 | +100.0% | 1.55% | – |
| CCXI | New | CHEMOCENTRYX INC | $46,873,000 | – | 757,000 | +100.0% | 1.52% | – |
| Buy | TRILLIUM THERAPEUTICS INC | $46,854,000 | +88.8% | 3,185,200 | +82.4% | 1.52% | +32.1% | |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO Lcall | $44,663,000 | – | 521,100 | +100.0% | 1.45% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $44,273,000 | +135.4% | 774,000 | +24.2% | 1.44% | +64.8% |
| CAH | New | CARDINAL HEALTH INC | $43,276,000 | – | 808,000 | +100.0% | 1.40% | – |
| BHVN | Sell | BIOHAVEN PHARMACTL HLDG CO L | $42,152,000 | -49.5% | 491,800 | -61.7% | 1.37% | -64.7% |
| ORGO | New | ORGANOGENESIS HLDGS INC | $41,577,000 | – | 5,521,500 | +100.0% | 1.35% | – |
| BHC | New | BAUSCH HEALTH COS INC | $41,018,000 | – | 1,972,000 | +100.0% | 1.33% | – |
| KDMN | Buy | KADMON HLDGS INC | $39,716,000 | +12.2% | 9,570,000 | +6.0% | 1.29% | -21.5% |
| XLRN | New | ACCELERON PHARMA INC | $38,254,000 | – | 299,000 | +100.0% | 1.24% | – |
| SRPT | New | SAREPTA TEHRAPEUTICS INC | $37,065,000 | – | 217,400 | +100.0% | 1.20% | – |
| ATHA | Buy | ATHIRA PHARMA INC | $35,753,000 | +88.7% | 1,043,873 | +1.7% | 1.16% | +32.1% |
| MDT | Buy | MEDTRONIC PLC | $35,259,000 | +87.4% | 301,000 | +66.3% | 1.14% | +31.3% |
| CTLT | Buy | CATALENT INC | $35,072,000 | +28.7% | 337,000 | +5.9% | 1.14% | -9.9% |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $34,813,000 | – | 147,300 | +100.0% | 1.13% | – |
| ANIK | Buy | ANIKA THERAPEUTICS INC | $33,085,000 | +55.4% | 731,000 | +21.5% | 1.07% | +8.7% |
| SGTX | New | SIGILON THERAPEUTICS INC | $33,045,000 | – | 688,000 | +100.0% | 1.07% | – |
| EXAS | New | EXACT SCIENCES CORP | $32,725,000 | – | 247,000 | +100.0% | 1.06% | – |
| EPIX | Buy | ESSA PHARMA INC | $30,517,000 | +111.8% | 2,558,000 | +22.5% | 0.99% | +48.4% |
| CRDF | New | CARDIFF ONCOLOGY INC | $28,910,000 | – | 1,607,000 | +100.0% | 0.94% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $28,755,000 | – | 300,000 | +100.0% | 0.93% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $28,205,000 | – | 527,600 | +100.0% | 0.92% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $27,660,000 | -47.3% | 2,000,000 | -43.9% | 0.90% | -63.1% |
| ZYME | Buy | ZYMEWORKS INC | $27,321,000 | +139.7% | 578,100 | +136.2% | 0.89% | +67.7% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $26,916,000 | – | 240,000 | +100.0% | 0.87% | – |
| ATEC | New | ALPHATEC HLDGS INC | $26,875,000 | – | 1,850,873 | +100.0% | 0.87% | – |
| BTAI | Buy | BIOXCEL THERAPEUTICS INC | $25,271,000 | +8.3% | 547,000 | +1.7% | 0.82% | -24.2% |
| ATRC | New | ATRICURE INC | $24,862,000 | – | 446,600 | +100.0% | 0.81% | – |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $24,817,000 | +19.2% | 1,239,000 | +23.9% | 0.81% | -16.6% |
| SHC | New | SOTERA HEALTH CO | $19,208,000 | – | 700,000 | +100.0% | 0.62% | – |
| CRIS | New | CURIS INC | $19,182,000 | – | 2,342,100 | +100.0% | 0.62% | – |
| SIBN | New | SI BONE INC | $19,133,000 | – | 639,884 | +100.0% | 0.62% | – |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $17,800,000 | +103.5% | 4,000,000 | +97.5% | 0.58% | +42.4% |
| BLU | New | BELLUS HEALTH INC NEW | $17,522,000 | – | 5,726,000 | +100.0% | 0.57% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $17,057,000 | – | 965,300 | +100.0% | 0.55% | – |
| NTLA | New | INTELLIA THERAPEUTICS INC | $16,483,000 | – | 303,000 | +100.0% | 0.54% | – |
| ALPN | Buy | ALPINE IMMUNE SCIENCES INC | $15,725,000 | +120.9% | 1,248,000 | +54.1% | 0.51% | +54.8% |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $15,538,000 | – | 125,690 | +100.0% | 0.50% | – |
| SGRY | New | SURGERY PARTNERS INC | $15,404,000 | – | 531,000 | +100.0% | 0.50% | – |
| CERT | New | CERTARA INC | $13,645,000 | – | 404,663 | +100.0% | 0.44% | – |
| STRO | New | SUTRO BIOPHARMA INC | $13,590,000 | – | 626,000 | +100.0% | 0.44% | – |
| CDXS | New | CODEXIS INC | $13,098,000 | – | 600,000 | +100.0% | 0.42% | – |
| HARP | Sell | HARPOON THERAPEUTICS INC | $13,039,000 | -34.5% | 785,000 | -33.0% | 0.42% | -54.2% |
| OLMA | New | OLEMA PHARMACEUTICALS INC | $12,982,000 | – | 270,000 | +100.0% | 0.42% | – |
| ONCS | New | ONCOSEC MED INC | $12,590,000 | – | 1,952,000 | +100.0% | 0.41% | – |
| KURA | New | KURA ONCOLOGY INC | $11,354,000 | – | 347,645 | +100.0% | 0.37% | – |
| TSHA | TAYSHA GENE THERAPIES INC | $10,404,000 | +18.5% | 392,000 | 0.0% | 0.34% | -17.0% | |
| CSTL | New | CASTLE BIOSCIENCES INC | $10,073,000 | – | 150,000 | +100.0% | 0.33% | – |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $9,844,000 | -7.1% | 1,435,000 | +0.3% | 0.32% | -34.8% |
| SCYX | New | SCYNEXIS INC | $9,601,000 | – | 1,255,000 | +100.0% | 0.31% | – |
| OSH | Buy | OAK STR HEALTH INC | $9,174,000 | +71.7% | 150,000 | +50.0% | 0.30% | +20.2% |
| GRTS | New | GRITSTONE ONCOLOGY INC | $8,361,000 | – | 2,122,064 | +100.0% | 0.27% | – |
| VSPRU | VESPER HEALTHCARE ACQSTN CORunit 99/99/9999 | $7,272,000 | +18.1% | 600,000 | 0.0% | 0.24% | -17.5% | |
| IGMS | New | IGM BIOSCIENCES INC | $7,063,000 | – | 80,000 | +100.0% | 0.23% | – |
| LGND | New | LIGAND PHARMACEUTICALS INC | $6,176,000 | – | 62,100 | +100.0% | 0.20% | – |
| COGT | New | COGENT BIOSCIENCES INC | $5,836,000 | – | 519,645 | +100.0% | 0.19% | – |
| OM | OUTSET MED INC | $5,684,000 | +13.7% | 100,000 | 0.0% | 0.18% | -20.3% | |
| BLSA | New | BCLS ACQUISITION CORP | $5,570,000 | – | 500,000 | +100.0% | 0.18% | – |
| ARYA | New | ARYA SCIENCES ACQUISITION CO | $5,425,000 | – | 500,000 | +100.0% | 0.18% | – |
| OCUL | New | OCULAR THERAPEUTIX INC | $5,175,000 | – | 250,000 | +100.0% | 0.17% | – |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $5,124,000 | +16.5% | 400,000 | 0.0% | 0.17% | -18.6% | |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $5,103,000 | – | 300,000 | +100.0% | 0.17% | – |
| PHAT | New | PHATHOM PHARMACEUTICALS INC | $5,066,000 | – | 152,500 | +100.0% | 0.16% | – |
| ALBO | New | ALBIREO PHARMA INC | $4,689,000 | – | 125,000 | +100.0% | 0.15% | – |
| HLXA | New | HELIX ACQUISITION CORP | $4,548,000 | – | 400,000 | +100.0% | 0.15% | – |
| LSAQ | New | LIFESCI ACQUISITION II CORP | $4,268,000 | – | 400,000 | +100.0% | 0.14% | – |
| PANAU | PANACEA ACQUISITION CORPunit 99/99/9999 | $3,828,000 | +6.3% | 300,000 | 0.0% | 0.12% | -25.7% | |
| BCTG | BCTG ACQUISITION CORP | $3,432,000 | +10.4% | 300,000 | 0.0% | 0.11% | -22.9% | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $3,131,000 | -61.5% | 92,574 | -71.9% | 0.10% | -73.0% |
| KROS | New | KEROS THERAPEUTICS INC | $2,822,000 | – | 40,000 | +100.0% | 0.09% | – |
| RCKT | New | ROCKET PHARMACEUTICALS INC | $2,742,000 | – | 50,000 | +100.0% | 0.09% | – |
| ANNX | Buy | ANNEXON INC | $1,752,000 | +54.2% | 70,000 | +86.3% | 0.06% | +7.5% |
| ACCD | ACCOLADE INC | $1,740,000 | +11.9% | 40,000 | 0.0% | 0.06% | -22.2% | |
| BCAB | New | BIOATLA INC | $1,701,000 | – | 50,000 | +100.0% | 0.06% | – |
| NRIX | NURIX THERAPEUTICS INC | $1,644,000 | -5.8% | 50,000 | 0.0% | 0.05% | -34.6% | |
| AMWL | AMERICAN WELL CORPcl a | $1,267,000 | -14.5% | 50,000 | 0.0% | 0.04% | -40.6% | |
| RLAY | RELAY THERAPEUTICS INC | $1,247,000 | -2.4% | 30,000 | 0.0% | 0.04% | -32.2% | |
| INZY | Sell | INOZYME PHARMA INC | $200,000 | -87.7% | 9,683 | -84.3% | 0.01% | -92.0% |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -25,000 | -100.0% | -0.09% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -150,000 | -100.0% | -0.25% | – |
| ARYBU | Exit | ARYA SCIENCES ACQUISITION CO | $0 | – | -500,000 | -100.0% | -0.25% | – |
| CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -1,000,000 | -100.0% | -0.27% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -1,550,000 | -100.0% | -0.35% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -118,000 | -100.0% | -0.39% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -1,050,800 | -100.0% | -0.61% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -757,400 | -100.0% | -0.65% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -206,000 | -100.0% | -0.66% | – |
| ADAP | Exit | ADAPTIMMUNE THERAPEUTICS PLSsponds adr | $0 | – | -2,084,700 | -100.0% | -0.77% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -7,324,000 | -100.0% | -0.85% | – |
| EXEL | Exit | EXELIXIS INC | $0 | – | -769,200 | -100.0% | -0.87% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -4,506,000 | -100.0% | -0.88% | – |
| HUM | Exit | HUMANA INC | $0 | – | -51,500 | -100.0% | -0.99% | – |
| IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -799,000 | -100.0% | -1.22% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORPORATION | $0 | – | -967,100 | -100.0% | -1.71% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -176,879 | -100.0% | -1.80% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -176,400 | -100.0% | -2.20% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -620,000 | -100.0% | -2.31% | – |
| BMYRT | Exit | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $0 | – | -22,684,932 | -100.0% | -2.37% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -118,300 | -100.0% | -2.42% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -315,100 | -100.0% | -4.15% | – |
| MRK | Exit | MERCK & CO. INC | $0 | – | -1,144,300 | -100.0% | -4.40% | – |
| SGEN | Exit | SEATTLE GENETICS INC | $0 | – | -531,100 | -100.0% | -4.82% | – |
| Exit | PFIZER INCcall | $0 | – | -6,500,000 | -100.0% | -11.06% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
| ARVINAS INC | 14 | Q3 2023 | 4.9% |
| ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
| SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
| IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
| NATERA INC | 13 | Q3 2023 | 1.9% |
| ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
| ABBVIE INC | 12 | Q2 2023 | 9.7% |
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
| AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
| ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
| Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
| IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
| ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
| PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
| Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
| Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-09 |
| SC 13G | 2024-03-27 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.